Skip to main content
Back to Investors

Sofinnova Partners Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: July 2026

Sofinnova Partners Investment Overview

Portfolio Companies
113
Total Invested
$4.1B
Average Investment
$53.1M

Sofinnova Partners's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
EnginZyme2024Non-equity AssistanceUndisclosedStockholm
Aledia2023Venture - Series UnknownUndisclosedGrenoble
HAYA Therapeutics2025GrantUndisclosedLausanne
Inspirna2022Series DUndisclosedNew York
CorVent Medical2024GrantUndisclosedFargo
Ingenix2026Seed$9.9MWarsaw
ProQR Therapeutics2026Post-IPO EquityUndisclosedLeiden
TISSIUM2026Series DUndisclosedParis
One Biosciences2026Grant$17.4MParis
P2 Science2026Venture - Series UnknownUndisclosedWoodbridge

Complete List of Sofinnova Partners Portfolio Companies (113)

Export
#CompanyStageAmountLocation
1EnginZymeNon-equity AssistanceUndisclosedStockholm, Sweden
2AlediaVenture - Series UnknownUndisclosedGrenoble, France
3HAYA TherapeuticsGrantUndisclosedLausanne, Switzerland
4InspirnaSeries DUndisclosedNew York, United States
5CorVent MedicalGrantUndisclosedFargo, United States
6IngenixSeed$9.9MWarsaw, Poland
7ProQR TherapeuticsPost-IPO EquityUndisclosedLeiden, The Netherlands
8TISSIUMSeries DUndisclosedParis, France
9One BiosciencesGrant$17.4MParis, France
10P2 ScienceVenture - Series UnknownUndisclosedWoodbridge, United States
BiotechnologyGreenTechLife ScienceManufacturing

EnginZyme is a biotechnology company that creates biomanufacturing techniques for the sustainable production of common goods.

Stockholm, Sweden
September 2024
Non-equity Assistance

Founder Contacts

19,000+ verified contacts

HardwareLightingManufacturingSemiconductor

Aledia develops and manufactures innovative light-emitting diodes (LEDs) based on a unique 3D architecture.

Grenoble, France
September 2023
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.

Lausanne, Switzerland
September 2025
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Inspirna is a biotechnology company developing drugs for the treatment of cancer.

New York, United States
July 2022
Series D

Founder Contacts

19,000+ verified contacts

Health CareMedical

We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.

Fargo, United States
June 2024
Grant

Founder Contacts

19,000+ verified contacts

Ingenix is building an AI Co-pilot for generating real-time hypotheses on clinical endpoints values and adverse events.

Warsaw, Poland
June 2026
$9.9M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareTherapeutics

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

Leiden, The Netherlands
June 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical Device

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Paris, France
June 2026
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.

Paris, France
June 2026
$17.4M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyChemicalManufacturingRenewable Energy

P2 Science produces bio-based chemicals from renewable materials for consumer and industrial use.

Woodbridge, United States
May 2026
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Paris, France
March 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.

Le Kremlin-bicêtre, France
February 2025
Grant

Founder Contacts

19,000+ verified contacts

MedicalMedical DeviceRobotics

Moon Surgical develops a new category of robotic surgery that enhances existing clinical practice with collaborative and adaptive robotics.

Paris, France
February 2025
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalPharmaceutical

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Copenhagen, Denmark
October 2025
$157.0M
Series C

Founder Contacts

19,000+ verified contacts

Biotechnology

Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.

London, United Kingdom
October 2025
$70.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

Cambridge, United Kingdom
October 2025
$13.3M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

AnalyticsBiotechnologyHealth CareMedical

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

Milan, Italy
October 2025
$97.8M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical DeviceTherapeutics

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

San Carlos, United States
September 2025
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalTherapeutics

Actithera is a molecular radiotherapeutic company that develops radioligand therapies.

Oslo, Norway
July 2025
$75.5M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Lyon, France
June 2025
$6.9M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.

Schlieren, Switzerland
May 2025
$130.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

SafeHeal develops Colovac, an innovative solution for the protection of digestive anastomosis, designed to reduce anastomotic complications.

Paris, France
April 2025
$39.9M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGenerative AILife SciencePharmaceutical

We are making biology programmable to transform health and sustainability for the benefit of all.

London, United Kingdom
February 2025
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

FitnessHealth CareNutritionWellness

Berry Street offers treatment for disordered eating, heart health, PCOD, liver disease, women's health, sports nutrition, and diabetes.

New York, United States
February 2025
$50.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth Care

Leucid is progressing novel cart therapies that produce a better and more durable response.

London, United Kingdom
February 2025
$8.9M
Series A

Founder Contacts

19,000+ verified contacts

Showing 1-25 of 113 portfolio companies

Frequently Asked Questions About Sofinnova Partners

How many companies has Sofinnova Partners invested in?

Sofinnova Partners has invested in 113 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Sofinnova Partners invest in?

Sofinnova Partners's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 24 different industry categories.

What is Sofinnova Partners's largest investment?

Among tracked funding rounds, Hemab received $157.0M in a Series C round. Sofinnova Partners's total known invested capital is $4.1B.

What is the average investment size for Sofinnova Partners?

Sofinnova Partners's average investment size is $53.1M across its portfolio of 113 companies.

What are Sofinnova Partners's most recent investments?

Recent Sofinnova Partners portfolio additions include EnginZyme, Aledia, HAYA Therapeutics, Inspirna, CorVent Medical. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors